Adults and children with susceptible bacterial infections may be prescribed Keflex, a capsule formulation of the cephalosporin antibiotic cephalexin. It is used for selected skin, urinary-tract and respiratory infections by disrupting bacterial cell-wall formation.
Keflex contains cephalexin, a first-generation cephalosporin antibiotic. It is prescribed for bacterial infections when the responsible organism is susceptible to cephalexin, including some skin infections, urinary tract infections and respiratory infections. It has no useful action against viruses such as influenza or the common cold. The FDA prescribing information describes cephalexin as a bactericidal antibacterial agent used across several infection types [1].
Cephalexin may be selected for infections involving:
The medicine is intended for bacterial infections, not viral symptoms. A sore throat, cough or fever does not automatically mean that an antibiotic is appropriate. The diagnosis, examination findings and local resistance patterns influence the choice.
Keflex is most active against many Gram-positive bacteria, including susceptible streptococci and staphylococci. Its activity against Gram-negative bacteria is more limited and varies between organisms.
Cephalexin belongs to the beta-lactam family and the first-generation cephalosporin class. It binds to bacterial penicillin-binding proteins, which are needed to build and cross-link the cell wall. The weakened wall can rupture as the bacterium grows, producing a bactericidal effect.
Human cells do not have bacterial cell walls. This difference allows cephalexin to act on susceptible bacteria without targeting the same structure in human tissue. The European Medicines Agency describes beta-lactam antibacterial activity through interference with bacterial cell-wall synthesis [2].
Keflex has useful activity against many susceptible Gram-positive bacteria. Coverage of Gram-negative bacteria is narrower than that of later-generation cephalosporins, and resistance can make treatment unsuitable.
Cephalexin should not be chosen solely because an infection appears bacterial. A culture and susceptibility test may be needed for recurrent infections, treatment failure, unusual infections or infections acquired in healthcare settings.
A practical point is easy to miss: improvement in pain or redness does not prove that the bacteria have been fully cleared. The prescriber’s duration remains relevant even when symptoms settle quickly.
The main concern is hypersensitivity to cephalexin or another beta-lactam antibiotic, alongside dose adjustment in reduced kidney function.
Penicillin allergy does not always prevent cephalexin use, but the type and severity of the earlier reaction matter. Cross-sensitivity is more concerning after an immediate severe reaction or a serious delayed skin reaction.
Keflex is not for you if:
Keflex is tolerated by many patients, yet gastrointestinal symptoms can occur. Commonly reported effects include diarrhoea, nausea, abdominal discomfort and vomiting. Loose stools may be mild and temporary, but severe or persistent diarrhoea requires medical assessment because antibiotic-associated colitis can occur.
| Pattern | Symptoms requiring attention |
|---|---|
| Common or mild | Nausea, diarrhoea, abdominal discomfort, vomiting, headache |
| Uncommon or serious | Hives, facial swelling, wheezing, severe rash, blistering skin, jaundice, bloody or persistent diarrhoea |
Nausea often improves when the capsule is taken with food and water. Mild diarrhoea can occur because antibiotics alter the balance of intestinal bacteria. Avoid self-treating severe diarrhoea with anti-diarrhoeal medicines until a clinician has assessed the symptoms.
A small number of patients develop antibiotic-associated colitis caused by Clostridioides difficile. Warning signs include frequent watery stools, blood or mucus, significant abdominal pain, fever or diarrhoea that continues after treatment ends.
Seek urgent medical help for breathing difficulty, swelling of the lips or tongue, faintness or rapidly spreading hives. A severe blistering or peeling rash also requires urgent assessment. These reactions can occur even when a person has previously taken a beta-lactam antibiotic without trouble.
Cephalexin can rarely affect the liver, blood cells or kidneys. Yellowing of the skin, unusually dark urine, marked bruising, reduced urination or extreme weakness should be reported promptly.
Keflex contains cephalexin, a first-generation cephalosporin antibiotic, in capsule form. Cephalexin is a bactericidal antibacterial agent that disrupts bacterial cell-wall formation and is used for susceptible bacterial infections, not viral illnesses.
The exact Keflex dosage is individualised according to the infection, its severity, age, kidney function and other medicines. The prescribed dose, frequency and treatment length should be followed exactly. Numeric regimens from another patient should not be copied because the same antibiotic can be used for conditions with different dosing requirements.
Clinical prescribing commonly divides cephalexin into repeated doses during the day, with the interval selected for the infection and the patient’s clearance of the medicine. More serious infections may require a different regimen from uncomplicated infections.
Key administration points include:
Food is not the central safety issue with cephalexin. Consistent timing is more useful than trying to create a complicated schedule around meals.
Treatment length depends on the infection and clinical response. Some courses are short, while others require longer treatment because the infection is deeper, recurrent or slow to resolve. A course may be extended, changed or stopped by the prescriber after reassessment.
Do not save unused capsules for a future illness. The next infection may involve a different organism and require another antibiotic. Sharing capsules can also expose another person to an unsuitable treatment.
The most suitable antibacterial agent depends on the infection site, organism, resistance pattern, allergy history, kidney function and route required. A different cephalosporin is not automatically a stronger version of Keflex.
| Active substance | Usual route | Clinical distinction |
|---|---|---|
| Cephalexin | Oral capsules or other oral forms | First-generation option for susceptible infections |
| Cefadroxil | Oral | Related first-generation cephalosporin with a different dosing profile |
| Cefazolin | Injection | Hospital or clinical-use option when parenteral treatment is required |
Cephalexin may be appropriate when oral treatment is suitable and the organism is susceptible. Cefazolin is used when an injectable route is needed, such as around surgery or for selected serious infections. Cefadroxil may be considered in specific situations, but its selection still depends on the diagnosis and susceptibility results.
Antibiotic choice should be narrowed by microbiology whenever possible. Broadening treatment without evidence can increase adverse effects and antimicrobial resistance.
Keflex is the proprietary name associated with cephalexin. Cefalexin is the spelling commonly used in the United Kingdom, while cephalexin is widely used internationally. A properly manufactured generic formulation contains the same active antibacterial substance and is assessed against the same therapeutic requirements.
Several practical errors can reduce treatment success or increase harm:
One easily overlooked issue is a change in diagnosis. If a skin infection forms a collection of pus, antibiotics alone may not resolve it; drainage and reassessment can become necessary.
Another is delayed allergy recognition. Hives, throat tightness or facial swelling after a capsule should not be treated as ordinary nausea.
In clinical practice, doctors usually focus first on whether an antibiotic is needed at all. They then consider the infection site, severity, allergy history, recent antibiotic exposure and kidney function before selecting cephalexin.
A doctor would also expect improvement to be assessed in context. Fever, pain, swelling or urinary symptoms may improve gradually rather than immediately, while worsening symptoms can indicate resistance, an abscess or a diagnosis requiring different treatment.
Cephalexin works best when the organism is susceptible and the dosing schedule is maintained. If symptoms worsen, new symptoms appear or there is no meaningful improvement within the timeframe given by the prescriber, reassessment may be needed rather than simply extending treatment.
Contact the prescriber if symptoms fail to improve within the timeframe provided or become worse. The NHS advises in its 2024 guidance that reassessment is needed when an infection is not responding because resistance, an abscess or an alternative diagnosis may be involved. Do not extend the course or double the dose independently.
Cephalexin can interact with some medicines, including probenecid, and extra care may be needed with medicines that affect kidney function. The MHRA’s 2024 antibiotic safety information supports checking regular medicines before treatment, including non-prescription products and supplements. Provide a complete list rather than naming only prescription medicines.
Both are first-generation cephalosporins, but they are different active substances with different pharmacokinetic profiles. The EMA’s 2023 product information describes antibiotic selection as dependent on susceptibility, infection site and patient factors rather than brand familiarity. A clinician may choose one over the other because of dosing practicality, local guidance or the individual clinical situation.
Cephalexin is not normally tapered because it is an antibacterial course rather than a medicine that produces physiological withdrawal. The WHO’s 2023 antibiotic guidance advises using antibiotics for the prescribed duration and avoiding unplanned interruption. Stopping early can leave infection insufficiently treated, while continuing after the prescribed course is also inappropriate without reassessment.
A previous severe immediate reaction to cephalexin or another cephalosporin can rule it out. NICE allergy guidance published in 2024 distinguishes potentially life-threatening reactions, such as anaphylaxis or severe skin reactions, from less severe symptoms. A clinician must review the exact reaction before selecting another beta-lactam.
Discuss the suspected infection, previous antibiotic reactions, kidney disease, pregnancy or breastfeeding, recent antibiotics and every regular medicine. The MHRA’s 2024 guidance recommends attention to allergy history and adverse effects when antibiotics are prescribed. Mention previous severe diarrhoea after antibiotics as well.
Diarrhoea is a recognised adverse effect of cephalexin and may be mild. The FDA’s 2023 prescribing information lists gastrointestinal reactions among reported effects, while persistent watery or bloody diarrhoea needs prompt assessment. Symptoms can appear during treatment or after it has ended.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
I took Keflex capsules for a skin infection and the redness started settling after several days. The improvement was real, although I had mild nausea after the first few doses and needed to take them with food. I completed the course rather than stopping when the skin looked better.
The urinary symptoms eased during the treatment and had cleared by the end of the prescribed course. The capsules were straightforward to take with a glass of water, and I found the schedule easy to keep alongside work.
Keflex helped with the infection affecting my skin. The swelling reduced steadily, and I was pleased that the treatment fitted into my normal routine without any major disruption.
I used the capsules for a bacterial respiratory infection and felt my breathing and chest discomfort improve as the course progressed. Taking each dose at similar times helped me remember them.
The treatment helped partly, but the improvement was slower than I expected. I developed loose stools near the end, so I contacted the doctor and was advised what symptoms would require further assessment.
